Ken Griffin Sol Gel Technologies Ltd. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 1,500 shares of SLGL stock, worth $810. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,500
Previous 5,400
72.22%
Holding current value
$810
Previous $4,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SLGL
# of Institutions
22Shares Held
5.35MCall Options Held
1.5KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L32.47MShares$1.33 Million0.03% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.1.23MShares$662,8750.01% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.920KShares$496,9790.01% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3229KShares$123,7560.03% of portfolio
-
Prosperity Wealth Management, Inc. San Ramon, CA163KShares$88,2360.04% of portfolio
About Sol-Gel Technologies Ltd.
- Ticker SLGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,129,500
- Market Cap $12.5M
- Description
- Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...